Desktop Site
|
19 Apr 24 | 16:00
|
Close
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Get Quote
*
Notices
|
S&P
BSE SENSEX
73,088.33
+599.34
+0.83 %
Corporate Announcement
Security Code
500124
Company
Dr Reddys Laboratories Ltd
Exchange Received Time
27/07/2017 14:12:48
Exchange Disseminated Time
27/07/2017 14:12:53
Time Taken
00:00:05
Outcome Of Board Meeting - Unaudited Financial Results For The Quarter Ended June 30, 2017. |
7/27/2017 2:12:48 PM
Further to our letter dated July 4, 2017, we would like to inform you that the Board of Directors of the Company at their meeting held on July 27, 2017 have interalia approved the Unaudited Financial Results of the Company for the quarter ended June 30, 2017.
In terms of the above, we are enclosing herewith the following:
1.
Unaudited Standalone and Consolidated Financial Statements of the Company for the quarter ended June 30, 2017 as per Indian Accounting Standards.
2. Unaudited Standalone and Consolidated Financial Statements of the Company for the quarter ended June 30, 2017 prepared in compliance with International Financial Reporting Standards (IFRS) as issued by International Accounting Standards Board (IASB).
3. Press Release on Financial Results of the Company for the quarter ended June 30, 2017.
Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the above along with Limited Review Reports of the Statutory Auditors on the Unaudited Standalone and Consolidated Financial Statements of the Company for the quarter ended June 30, 2017.
Attachment
<< Back
Recently Viewed